• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Angiogenesis and access to vasculature as a target in gastrointestinal tumors and predictive biomarkers identification: an open challenge.

作者信息

Lai Eleonora, Ziranu Pina, Pezzella Francesco, Pretta Andrea, Liscia Nicole, Hu Zhiwei

机构信息

Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.

Nuffield Division of Clinical Laboratory Science-Radcliffe Department of Medicine (NDCLS-RDM) John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.

出版信息

Front Oncol. 2024 May 20;14:1428174. doi: 10.3389/fonc.2024.1428174. eCollection 2024.

DOI:10.3389/fonc.2024.1428174
PMID:38832255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11145327/
Abstract
摘要

相似文献

1
Editorial: Angiogenesis and access to vasculature as a target in gastrointestinal tumors and predictive biomarkers identification: an open challenge.社论：血管生成与作为胃肠道肿瘤靶点的血管通路以及预测性生物标志物的识别：一项公开挑战。
Front Oncol. 2024 May 20;14:1428174. doi: 10.3389/fonc.2024.1428174. eCollection 2024.
2
Broad targeting of angiogenesis for cancer prevention and therapy.针对癌症预防和治疗的广泛血管生成靶向作用。
Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S224-S243. doi: 10.1016/j.semcancer.2015.01.001. Epub 2015 Jan 16.
3
Targeting angiogenesis in gastrointestinal tumors: current challenges.靶向胃肠道肿瘤血管生成：当前挑战
Transl Gastroenterol Hepatol. 2016 Sep 6;1:67. doi: 10.21037/tgh.2016.08.04. eCollection 2016.
4
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies.抗血管生成蛋白激酶抑制剂和血管破坏剂在癌症中的安全性和耐受性：重点关注胃肠道恶性肿瘤。
Drug Saf. 2019 Feb;42(2):159-179. doi: 10.1007/s40264-018-0776-6.
5
Vasculature-specific MRI reveals differential anti-angiogenic effects of a biomimetic peptide in an orthotopic breast cancer model.血管特异性磁共振成像揭示了一种仿生肽在原位乳腺癌模型中的不同抗血管生成作用。
Angiogenesis. 2015 Apr;18(2):125-36. doi: 10.1007/s10456-014-9450-5. Epub 2014 Nov 19.
6
Angiogenesis of gastrointestinal tumours and their metastases--a target for intervention?胃肠道肿瘤及其转移灶的血管生成——一个干预靶点？
Eur J Cancer. 2004 Jun;40(9):1302-13. doi: 10.1016/j.ejca.2004.02.015.
7
Intussusceptive angiogenesis as a key therapeutic target for cancer therapy.作为癌症治疗的关键治疗靶点的内陷性血管生成。
Life Sci. 2020 Jul 1;252:117670. doi: 10.1016/j.lfs.2020.117670. Epub 2020 Apr 13.
8
The role of tumor angiogenesis as a therapeutic target in colorectal cancer.肿瘤血管生成作为结直肠癌治疗靶点的作用。
Expert Rev Anticancer Ther. 2018 Mar;18(3):251-266. doi: 10.1080/14737140.2018.1428092. Epub 2018 Jan 19.
9
Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs).抗血管生成药物耐药性：非编码 RNA（microRNAs 和长非编码 RNA）的作用和靶向。
Curr Mol Pharmacol. 2023;16(8):855-869. doi: 10.2174/1874467216666221206100135.
10
Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.表皮生长因子受体（EGFR）和血管内皮生长因子受体（VEGFR）靶向抗癌药物生物标志物鉴定的进展与挑战
Drug Resist Updat. 2008 Jun;11(3):99-109. doi: 10.1016/j.drup.2008.04.001. Epub 2008 Jun 2.

本文引用的文献

1
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging.晚期结直肠癌患者抗血管生成治疗反应的预测：从生物学因素到功能成像
Cancers (Basel). 2024 Mar 30;16(7):1364. doi: 10.3390/cancers16071364.
2
Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice.所有抗血管生成药物在二线转移性结直肠癌治疗中都一样吗？临床实践专家意见
Front Oncol. 2021 May 10;11:637823. doi: 10.3389/fonc.2021.637823. eCollection 2021.
3
Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer.分子生物学驱动的转移性结直肠癌治疗
Cancers (Basel). 2020 May 13;12(5):1214. doi: 10.3390/cancers12051214.
4
Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases.具有治疗血管生成依赖性以及巨噬细胞相关人类疾病潜力的抗组织因子治疗性抗体样免疫缀合物。
Antibodies (Basel). 2018 Mar;7(1). doi: 10.3390/antib7010008. Epub 2018 Jan 23.
5
Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy.组织因子是针对因子VII的免疫疗法和光动力疗法的血管生成特异性受体。
Angiogenesis. 2017 Feb;20(1):85-96. doi: 10.1007/s10456-016-9530-9. Epub 2016 Nov 2.
6
Hallmarks of cancer: the next generation.癌症的特征：下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
7
In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease.血管内皮细胞中组织因子的原位检测：与人类乳腺疾病恶性表型的相关性
Nat Med. 1996 Feb;2(2):209-15. doi: 10.1038/nm0296-209.
8
Tumor angiogenesis and tissue factor.肿瘤血管生成与组织因子
Nat Med. 1996 Feb;2(2):167-8. doi: 10.1038/nm0296-167.
9
Angiogenesis in cancer, vascular, rheumatoid and other disease.癌症、血管疾病、类风湿性疾病及其他疾病中的血管生成。
Nat Med. 1995 Jan;1(1):27-31. doi: 10.1038/nm0195-27.